Antithrombin III (ATIII)) replacement therapy in patients with sepsis and/or postsurgical complications: A controlled double-blind, randomized, multicenter study

Intensive Care Medicine

Volumn 24, Issue 4, 1998, Pages 336-342

  Baudo, F ^a   Caimi, T M ^a   DeCataldo, F ^a   Ravizza, A ^a   Arlati, S ^a   Casella, G ^a   Carugo, D ^a   Palareti, G ^b   Legnani, C ^b   Ridolfi, L ^b   Rossi, R ^b   D'Angelo, A ^c   Crippa, L ^c   Giudici, D ^c   Gallioli, G ^c   Wolfler, A ^c   Calori, G ^c  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Acquired ATIII deficiency; ATIII replacement therapy; Septic shock

Indexed keywords

ANTITHROMBIN III; ANTITHROMBIN III CONCENTRATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; TIME;

EID: 7144251856     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050576     Document Type: Article

References (23)

1. Buller HR, Ten Cate JW (1989) Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications and treatment with anti-thrombin III concentrate. Am J Med 87 [Suppl 3B]: 44s-48s
2. Blauhut B, Necek S, Vinazzer H, Bergmann H (1982) Substitution therapy with an antithrombin III concentrate in shock and DIC. Thromb Res 27: 271-278
3. Hesselvik JF, Malm J, Dahlback B, Blomback M (1991) Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Hemost 62: 126-129
4. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P (1992) Septic shock, multi organ failure and disseminated intravascular coagulation. Compared pattern of ATIII, protein C, protein S deficiencies. Chest 101: 816-823
5. Blauhut B, Kramar H, Vinazzer H, Bergmann H (1984) Substitution of antithrombin III in shock and DIC: a randomized study. Thromb Res 39: 81-89
6. Wilson RF, Mammen EF, Robson MC, Heggers JP, Soullier G, DePoli PA (1986) Antithrombin, prekallikrein and fibronectin levels in surgical patients. Arch Surg 121: 635-643
7. Sandset PM, Roise O, Aasen AO, Abildgaard U (1989) Extrinsic pathway inhibitor in post operative post traumatic septicaemia: increased levels in fatal cases. Hemostasis 19: 189-195
8. Hesselvik JF, Blomback M, Brodin B, Maller R (1989) Coagulation, fibrinolysis and kallikrein systems in sepsis: relation to outcome. Crit Care Med 17: 724-733
9. Lammle B, Tran TM, Ritz R, Duckert F (1984) Plasma prekallikrein, factor XII, ATIII, Cl-inhibitor and α2 macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Clin Pathol 82: 396-404
10. Maki M, Terao T, Ikenoue T, Takemura T, Sekiba K, Shirakawa K, Soma H (1987) Clinical evaluation of antithrombin concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Gynecol Obstet Invest 23: 230-240
11. Vinazzer H (1989) Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation. Semin Thromb Hemost 15: 347-352
12. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J (1993) Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104: 882-888
13. th European Congress on Intensive Care Medicine, pp 385-390, Glasgow
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829
15. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis (1992). Crit Care Med 20: 864-874
16. La Gall JR, Loirat P. Alperovith A, Glaser P, Granthil C, Mathieu D, Mercier P, Thomas R, Villers D (1984) A simplified acute physiology score for ICU patients. Crit Care Med 12: 975-977
17. Goris RJA, Boekhorst TP, Nuytinck JKS, Gimbrere JSF (1985) Multiple organ failure. Arch Surg 120: 1109-1115
18. Lechner K, Kyrle PA (1995) Antithrombin III concentrates - are they clinically useful? Thromb Haemost 73: 340-348
19. Salvo I, DeCian W, Musicco M, Langer M, Piadena R, Wolfler A, Mowtani C, Magni E (1995) The Italian SEPSIS study: preliminary results on incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 21: S244-S249
20. Dickneite G, Paques EP (1993) Reduction of mortality with antithrombin III in septicaemia rats: a study of Klebsiella pneumoniae induced sepsis. Thromb Haemost 69: 98-102
21. Kessler CM, Tang ZC, Jacobs HM, Szymanski LM (1997) The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity. Blood 89: 4393-4401
22. Jochum M (1995) Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines and soluble adhesion molecules in acute inflammation Semin Hematol 32: 19-32
23. Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J (1996) Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 88: 881-886